Current Report Filing (8-k)
February 03 2021 - 09:20AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
February 2, 2021
Date
of Report (Date of earliest event reported)
EVIO, Inc.
(Exact
name of registrant as specified in its charter)
Colorado |
|
000-12350 |
|
47-1890509 |
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
2654 W. Horizon Ridge Parkway, Ste B5-208
Henderson, NV
|
|
89052 |
(Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code (702)
748-9944
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General
Instruction A.2. below):
[ ] |
Written
communications pursuant to Rule 425 under Securities Act (17 CFR
230.425) |
|
|
[ ] |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
|
|
[ ] |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
|
|
[ ] |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
N/A |
|
N/A |
|
N/A |
Indicate
by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (§230.405 of
this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging
growth company [X]
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.
Item
2.01 Completion of Acquisition or Disposition of
Assets.
Effective
February 1, 2021, EVIO, Inc. completed the sale of the assets of
Smith Scientific Inc. dba EVIO Labs Medford to SSIAC, LLC. The sale
was performed in exchange for a combination of cash, assumption of
liabilities and forgiveness of debt to Anthony Smith valued at
approximately $523,000. The sale was pursuant to the Stipulated
Settlement Agreement with the Oregon Liquor Control Commission
dated November 19, 2020.
Item
7.01 Regulation FD Disclosure.
EVIO
Labs Portland in Tigard, OR continues to provide analytical testing
services to cannabis, CBD and hemp producers statewide, as well as
hemp and CBD clients nationwide. HempTesting.com customers are
being served from our Berkeley, CA and Portland, OR locations.
Keystone Labs continues to serve Canadian cannabis, hemp and CBD
customers across Canada.
Forward-Looking Statements
Statements
contained in this current report that are not statements of
historical fact are intended to be and are hereby identified as
“forward-looking statements” for purposes of the safe harbor
provided by the Private Securities Litigation Reform Act of 1995.
Generally, forward-looking statements include expressed
expectations of future events and the assumptions on which the
expressed expectations are based. All forward-looking statements
are inherently uncertain as they are based on various expectations
and assumptions concerning future events and they are subject to
numerous known and unknown risks and uncertainties which could
cause actual events or results to differ materially from those
projected. The Company undertakes no obligation to update or revise
this current report to reflect future developments except as
otherwise required by the Securities Exchange Act of
1934.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
EVIO,
INC., |
|
|
|
Date:
February 3, 2021 |
By: |
/s/
Lori Glauser |
|
|
Lori
Glauser |
|
|
Chief
Executive Officer |